Initiate Insulin by Aggressive Titration and Education (INITIATE)
The DOI matches its Crossref record, with a small difference in title or year; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Objective Insulin is often postponed for years because initiation is time-consuming. We sought to compare initiation of insulin individually and in groups with respect to change in A1C and several other parameters in type 2 diabetic patients. Research design and methods A randomized (1:1), multicenter, two-arm, parallel design study with a recruiting period of up to 14 weeks and a 24-week treatment period. Either in groups of 4-8 or individually, using the same personnel and education program, 121 insulin-naive type 2 diabetic patients with an A1C of 7.0-12.0% were randomized to initiate bedtime insulin glargine. The patients visited the treatment center before and at the time of insulin initiation and at 6, 12, and 24 weeks. Patients self-adjusted the insulin dose to achieve a fasting plasma glucose 4.0-5.5 mmol/l. Results At 24 weeks, mean +/- SE A1C had decreased from 8.7 +/- 0.2 to 6.9 +/- 0.1% in those treated individually and from 8.8 +/- 0.2 to 6.8 +/- 0.1% in those in groups (not significant [NS]). Insulin doses averaged 62 +/- 5 IU and 56 +/- 5 IU at 24 weeks (NS), respectively. The frequency of hypoglycemia was similar. The total time (visits and phone calls) spent in initiating insulin in the patients in groups (2.2 +/- 0.1 h) was 48% less than in those treated individually (4.2 +/- 0.2 h). Diabetes treatment satisfaction improved significantly in both sets of patients. Conclusions Similar glycemic control and treatment satisfaction can be achieved by initiating in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, several insulin treat-to-target trials have safely used dose titration protocols in individuals not at target A1C to reach lower than”
From Targets for Glycemic Control (2018) · cites this paper as [43]
In the citing paper
“A study performed on insulin initiation, and titration suggested that individual treatment rather than group treatment effectively controlled body weight [27].”
Citations
Cites
Riddle (2003) · doi:10.2337/diacare.26.11.3080 · Cited by 1,479
Minimization: A new method of assigning patients to treatment and control groups
Taves, D. R. (1974) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1974155443 · Cited by 891 · cited 1×
“Randomization was performed centrally, using the minimization of differences method (11).”
MethodYki-Järvinen, H., Dressler, A., Ziemen, M., & HOE 901/300s Study Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1130 · Cited by 579
Initiating Insulin Therapy in Type 2 Diabetes
Raskin, P., Allen, E., Hollander, P., Lewin, A., Gabbay, R. A., Hu, P., Bode, B., Garber, A., & for the INITIATE Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.2.260 · Cited by 560
Wright, A., Burden, A. C. F., Paisey, R. B., Cull, C. A., Holman, R. R., & for the U.K. Prospective Diabetes Study Group (2002) · Diabetes Care · doi:10.2337/diacare.25.2.330 · Cited by 556
Insulin glargine or NPH combined with metformin in type 2 diabetes: The LANMET study
Yki-Järvinen, H., Kauppinen-Mäkelin, R., Tiikkainen, M., Vähätalo, M., Virtamo, H., Nikkilä, K., Tulokas, T., Hulme, S., Hardy, K., McNulty, S., et al. (2006) · Diabetologia · doi:10.1007/s00125-005-0132-0 · Cited by 434
Self-citationYki-Järvinen, H., Ryysy, L., Nikkilä, K., Tulokas, T., Vanamo, R., & Heikkilä, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00002 · Cited by 433
Self-citationJanka, H. U., Plewe, G., Riddle, M. C., Kliebe-Frisch, C., Schweitzer, M. A., & Yki-Järvinen, H. (2005) · Diabetes Care · doi:10.2337/diacare.28.2.254 · Cited by 414
Patient perceptions of diabetes and diabetes therapy: assessing quality of life
Bradley, C., & Speight, J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.279 · Cited by 362
Fritsche, A., Schweitzer, M. A., Hring, H.-U., & and the 4001 Study Group* (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00006 · Cited by 331
Cited by
Items 101–138 of 138
Zhang, T., Zhao, Y., Du, T., Zhang, X., Li, X., Liu, R., Wang, Y.-L., Chen, B., He, L., & Li, W. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s169000 · Cited by 6
Winkley, K., Sorsa, T., Tian, Q., Reece, I., Fitzgerald, C., Chamley, M., Ismail, K., Forbes, A., & Upsher, R. J. (2023) · Pilot and Feasibility Studies · doi:10.1186/s40814-023-01318-x · Cited by 10
Galdo, J. A., Thurston, M. M., & Bourg, C. A. (2014) · Clinical Diabetes · doi:10.2337/diaclin.32.2.66 · Cited by 5
Karagianni, P., Pοlyzos, S. A., Kartali, N., Zografou, I., & Sambanis, C. (2013) · Advances in Medical Sciences · doi:10.2478/v10039-012-0078-7 · Cited by 4
Esposito, K., Maiorino, M. I., Bellastella, G., Chiodini, P., & Giugliano, D. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0134 · Cited by 4
Insulin glargine in type 2 diabetes in everyday clinical practice: 7 years experience
Schreiber, S. A. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00842.x · Cited by 4
‘Introduction to Insulin’ classes: flexible approach to insulin initiation
Greenslade, M. E., Lunt, H., Kendall, D., & Frampton, C. M. A. (2009) · Practical Diabetes · doi:10.1002/pdi.1357 · Cited by 4
Perfetti, R. (2013) · Diabetes Management · doi:10.2217/dmt.13.51 · Cited by 4
Falcetta, P., Zilich, R., Baccetti, F., Baronti, W., Masi, D., Morviducci, L., Musacchio, N., Muselli, M., Ozzello, A., Rossi, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf229 · Cited by 3
Deerochanawong, C., Leelawattana, R., Kosachunhanun, N., & Tantiwong, P. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420935930 · Cited by 3
Xu, W., Qiu, L., Luo, S., Li, M., Weng, J., Guo, X., & Ji, L. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2709 · Cited by 3
Odawara, M., Kadowaki, T., & Naito, Y. (2014) · Diabetology International · doi:10.1007/s13340-014-0176-9 · Cited by 3
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M. A., Peters, A. L., Τσάπας, Α., Wender, R. C., & Matthews, D. R. (2012) · Cited by 3
Structure and properties of insulin
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820234-0.00004-4 · Cited by 5
Soidán, F. J. G. (2013) · Avances en Diabetología · doi:10.1016/j.avdiab.2013.01.002 · Cited by 2
(SFD), U. P. D. P. P. P. L. S. F. D. D. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70660-0 · Cited by 2
VersorgungsLeitlinie, N. (2011) · Cited by 2
Soto-González, A., & Bellido, D. (2013) · journal of Diabetes Research and Clinical Metabolism · doi:10.7243/2050-0866-2-20 · Cited by 1
“In this regard, a number of studies have shown that patients with T2DM with inadequate glycemic control after treatment with OADs alone could achieve HbA1c levels ≤7% by the addition of basal insulin analogs [8-12].”
BackgroundFurukawa, K., Yamaaki, N., Fujimoto, A., Ohyama, K., & Muramoto, H. (2016) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2016.63022 · Cited by 1
Cai, X., Luo, Y., Han, X., & Ji, L. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20131186 · Cited by 1
Diabetes Project Aalst: Chronic Disease Management
Nobels, F. R. E., Amant, M., Samyn, E., Haeck, C., Vandenberk, A.-M., Vinken, S., Sunaert, P., Bastiaens, H., & Crombrugge, P. V. (2008) · Cited by 1
Insulin Management in Type 2 Diabetes
Crasto, W., Jarvis, J., & Davies, M. J. (2016) · Springer eBooks · doi:10.1007/978-3-319-10939-8_4 · Cited by 1
Self-citationConsensus ADA/EASD 2009 : l’algorithme pour le traitement médical du diabète de type 2 est utile !
Sauvanet, J.-P. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70035-3 · Cited by 3
Davies, M. J., Jarvis, J., & Khunti, K. (2008) · Intern J Endocrinol Metab
Self-citationGlinkina, I. V. (2008) · Diabetes Mellitus · doi:10.14341/2072-0351-5593
Jones, H., Berard, L., Macneill, G., Whitham, D., & Yu, C. H. Y. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.035 · Cited by 1
Initiating Insulin Therapy in Group Sessions
Brett, A. S. (2007) · Journal watch · doi:10.1056/jw200707100000004
Appannah, A., Rice, T., & Ogrin, R. (2017) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2017.05.003
Economic Evaluation of Predominant Disease in Developing Countries
Shafie, A. A., & Ng, C. H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-811228-1.00008-x
Dunning, M. P. T. (2009) · Wiley eBooks · doi:10.1002/9781444320893.ch5
Dunning, M. P. T. (2009) · Wiley eBooks · doi:10.1002/9781444320893.ch16
Health-Related Quality of life in patients with type 2 diabetes undergoing therapy intensification
Hajos, T. R. S. (2013) · Pure Amsterdam UMC
Current literature in diabetes
(2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.812
Insulin Therapy in Type 2 Diabetes
Wyne, K. L., & Mora, P. (2007) · CRC Press eBooks · doi:10.3109/9780849379581-15
Ghafoor, E., & Eichorst, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22106-4.00021-8
Bolli, G. B., Home, P., Lepore, M., Riddle, M. C., Porcellati, F., Fanelli, C. G., Lucidi, P., Yki‐Järvinen, H., Becker, R. H. A., & Owens, D. R. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70751
“Glargine U100 may remain the most prescribed BI for the time being, and the prime target for biosimilars [124], but the introduction of further LAIAs emphasizes that the problems of sub-cutaneous administration of BI, although usefully ameliorated, have not been eliminated [3, 5].”
Insulin in the management of type 2 diabetes
Fonseca, V. A., Pendergrass, M., & McDuffie, R. H. (2009) · Springer eBooks · doi:10.1007/978-1-84882-103-3_4
Advancing nursing jurisdiction in diabetes care
Davis, R. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Metadata
- Authors
- Yki-Järvinen, H., Juurinen, L., Alvarsson, M., Bystedt, T., Caldwell, I., Davies, M., Lahdenperä, S., Nijpels, G., & Vähätalo, M.
- Affiliations
- University of Helsinki, Helsinki, Finland
- University of Helsinki (FI)
- Karolinska University Hospital (SE)
- Bolton NHS Foundation Trust (GB)
- Leicester Royal Infirmary (GB)
- Sanofi-Aventis, Helsinki, Finland
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Turku Health Center, Turku, Finland
- ORCID
- Davies, Melanie
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 30
- Issue
- 6
- Pages
- 1364-1369
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2163457223
- Cited by
- 139
- References
- 13
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 3 · 2020: 5 · 2019: 6 · 2018: 5 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 16 · 2013: 17 · 2012: 11
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- insulin initiation, type 2 diabetes, insulin glargine, bedtime insulin, patient education, insulin dose adjustment, glycemic control, HbA1c, hypoglycemia, treatment satisfaction
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Female, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Male, Patient Education as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.